VBIOvs its industry peers
A metric-by-metric comparison of VBIO against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VBIOThis | $47M#6 | — | 11.1x#6 | 60.3x#2 | -33.7%#3 | -57.0%#6 | -1012.6%#1 | -209.1%#4 | — | — | — | — |
| IBO | $58M#1 | 0.6x#1 | 5.3x#4 | 1797.2x#6 | — | 52.1%#1 | -13381.3%#5 | -110.0%#3 | -18.9%#1 | — | — | — |
| SER | $57M#2 | — | — | 436.7x#5 | 132.1%#2 | -72.2%#8 | -18478.5%#6 | — | — | 5#1 | — | — |
| NMAD | $56M#3 | — | 2.4x#2 | 281.0x#4 | — | -69.5%#7 | -2553.8%#3 | -25.4%#1 | — | — | — | — |
| PDSB | $55M#4 | — | — | — | — | 8.3%#5 | — | — | -541.6%#4 | — | — | — |
| HYPD | $51M#5 | — | 0.5x#1 | 62.3x#3 | 1318.8%#1 | 9.0%#4 | -5743.5%#4 | -44.5%#2 | -46.8%#2 | — | — | — |
| ELTX | $47M#7 | — | 5.9x#5 | 20.2x#1 | -91.9%#4 | 23.8%#2 | -1639.0%#2 | -498.6%#6 | — | — | — | — |
| HOWL | $46M#8 | — | 2.8x#3 | — | — | 13.7%#3 | — | -373.3%#5 | -229.9%#3 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice